1 – 10 of 70
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor : a single- and multiple-dose first-in-human study in healthy participants
(
- Contribution to journal › Article
- 2019
-
Mark
Physciosporin suppresses the proliferation, motility and tumourigenesis of colorectal cancer cells
(
- Contribution to journal › Article
- 2018
-
Mark
Acute kidney injury following coronary angiography : a nationwide study of incidence, risk factors and long-term outcomes
(
- Contribution to journal › Article
-
Mark
Design, synthesis and evaluation of potent and selective inhibitors of mono-(ADP-ribosyl)transferases PARP10 and PARP14
(
- Contribution to journal › Article
-
Mark
Structure-activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity
(
- Contribution to journal › Article
- 2017
-
Mark
Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity
(
- Contribution to journal › Article
-
Mark
Acute doses of caffeine shift nervous system cell expression profiles toward promotion of neuronal projection growth
(
- Contribution to journal › Article
-
Mark
Design and synthesis of potent inhibitors of the mono(ADP-ribosyl)transferase, PARP14
(
- Contribution to journal › Article
- 2016
-
Mark
Inhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosis
(
- Contribution to journal › Article
-
Mark
Population Pharmacokinetic Modelling of FE 999049, a Recombinant Human Follicle-Stimulating Hormone, in Healthy Women After Single Ascending Doses
(
- Contribution to journal › Article